Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alisa Jennifer Prager, M.D.

Concepts (136)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Glaucoma7202211591.280 Why?
Visual Fields3202110490.940 Why?
Visual Field Tests320213830.820 Why?
Neurocutaneous Syndromes12021510.750 Why?
Arteriovenous Fistula120213150.610 Why?
Tomography, Optical Coherence3202226570.590 Why?
Eye Diseases220226680.590 Why?
Fluorescein Angiography120219400.560 Why?
Macula Lutea120171510.550 Why?
Retinal Vessels120217720.520 Why?
Glaucoma, Open-Angle120217110.490 Why?
Vision Disorders1202110590.460 Why?
Retinal Ganglion Cells120177710.400 Why?
Visual Acuity2201725300.400 Why?
Disease Management1202124580.360 Why?
Medicare2201865660.340 Why?
Brain Diseases1201515640.260 Why?
Self Report1201635580.250 Why?
Health Care Costs1201632090.210 Why?
Patient Acceptance of Health Care1201630230.210 Why?
Magnetic Resonance Imaging32021354230.210 Why?
Hospitalization22018102620.200 Why?
Medicare Part D220163280.190 Why?
Brain Neoplasms4201588600.190 Why?
beta-Alanine12021740.190 Why?
Quality of Life42022128050.190 Why?
Ocular Hypertension120221980.190 Why?
Blastomycosis12019160.180 Why?
Fundus Oculi120214730.180 Why?
Glioma1201534010.180 Why?
Benzoates120212180.170 Why?
Neoplasm Recurrence, Local2201592300.170 Why?
Dacryocystitis12019700.170 Why?
Scotoma120171390.140 Why?
Health Plan Implementation220163510.130 Why?
Vision, Binocular120172130.130 Why?
Disease Progression32022132800.120 Why?
Hepatocyte Growth Factor120132700.110 Why?
Osteopontin120132960.100 Why?
Dacarbazine120155670.100 Why?
Insulin-Like Growth Factor Binding Protein 3120134230.100 Why?
Drug Costs2201611050.100 Why?
Health Services Research1201818360.100 Why?
Prostatic Neoplasms12013110740.090 Why?
Confidence Intervals1201629700.090 Why?
Cost Savings120159260.090 Why?
Cross-Sectional Studies42018250430.090 Why?
Brain Stem Neoplasms120112040.090 Why?
Area Under Curve1201316550.090 Why?
Antihypertensive Agents2201620470.090 Why?
Metabolic Networks and Pathways120137820.080 Why?
Prescription Drugs120165950.080 Why?
Ophthalmic Solutions220223170.080 Why?
Aged1020181632530.080 Why?
Glioblastoma2201334810.080 Why?
Radiotherapy1201515250.080 Why?
Artificial Intelligence1202122130.080 Why?
Humans2020227442200.080 Why?
Interferon-alpha120118950.070 Why?
Kidney Transplantation1202242510.070 Why?
Female1520213801970.070 Why?
Enzyme-Linked Immunosorbent Assay1201338710.070 Why?
Molecular Imaging120138310.070 Why?
Polyethylene Glycols1201111810.070 Why?
ROC Curve1201335270.070 Why?
Radiation Injuries1201311780.070 Why?
Male1420183500270.070 Why?
Diagnosis, Differential12021129610.070 Why?
Insurance Coverage1201619010.060 Why?
Comorbidity12018103870.060 Why?
Medication Adherence1201520620.060 Why?
Diabetes Mellitus1202257550.060 Why?
Prostate-Specific Antigen1201324780.060 Why?
Neurosurgical Procedures1201520030.060 Why?
Radiosurgery1201313280.060 Why?
Aged, 80 and over32018577680.060 Why?
Databases, Factual1201877300.060 Why?
Odds Ratio1201698490.060 Why?
Longitudinal Studies22016139900.060 Why?
Middle Aged620212133670.050 Why?
United States42018698670.050 Why?
Hypertension1202284800.050 Why?
Socioeconomic Factors1201677840.050 Why?
Retrospective Studies32022774260.050 Why?
Sensitivity and Specificity22013147260.050 Why?
Logistic Models12016134090.050 Why?
Diffusion Magnetic Resonance Imaging1201227370.050 Why?
Antineoplastic Agents22015136680.050 Why?
Neoplasm Staging12013110070.040 Why?
Electromagnetic Fields120002980.040 Why?
Incidence12016209450.040 Why?
Prognosis22013290500.030 Why?
Intraocular Pressure1202212740.030 Why?
Sickness Impact Profile120173040.030 Why?
Prospective Studies22017532800.030 Why?
Antibodies, Monoclonal1201292750.030 Why?
Follow-Up Studies12017390450.030 Why?
Risk Assessment12016233370.030 Why?
Cysts120196790.030 Why?
Financing, Personal120163080.030 Why?
Visual Cortex1200011490.030 Why?
Graft Rejection1202243990.020 Why?
Drug Utilization1201511830.020 Why?
Tissue Distribution1201323350.020 Why?
Necrosis1201316430.020 Why?
Gene Amplification1201310620.020 Why?
Income1201619130.020 Why?
Brain12013264130.020 Why?
Preoperative Care1201322460.010 Why?
Up-Regulation1201342170.010 Why?
Lacrimal Apparatus119662250.010 Why?
Drug Administration Schedule1201149290.010 Why?
Health Expenditures1201623480.010 Why?
Recombinant Proteins1201166120.010 Why?
Disease-Free Survival1201168930.010 Why?
Phosphenes12000440.010 Why?
Combined Modality Therapy1201186280.010 Why?
Sensory Thresholds120003940.010 Why?
Dose-Response Relationship, Radiation120008760.010 Why?
Adolescent32013857590.010 Why?
Reproducibility of Results12013199070.010 Why?
Electromyography1200013910.010 Why?
Electric Stimulation1200017700.010 Why?
Reference Values1200049820.010 Why?
Adult420132140350.010 Why?
Motor Cortex120009860.010 Why?
Infant22011351290.010 Why?
Child, Preschool22011409920.010 Why?
Transcranial Magnetic Stimulation1200014320.010 Why?
Lung Neoplasms12013130960.010 Why?
Young Adult12013564360.000 Why?
Aging1196686610.000 Why?
Breast Neoplasms12013208170.000 Why?
Child22011776790.000 Why?
Conjunctivitis119661580.000 Why?
Atrophy1196615820.000 Why?
Prager's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (136)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.